- Home
- OTTR vs RLAY Comparison
OTTR vs RLAY Comparison
Compare OTTR & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OTTR | RLAY |
|---|---|---|
| Founded | 1907 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 4.1B |
| IPO Year | 2009 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OTTR | RLAY |
|---|---|---|
| Price | $88.44 | $18.56 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 13 |
| Target Price | ★ $90.50 | $27.58 |
| AVG Volume (30 Days) | 158.1K | ★ 2.8M |
| Earning Date | 11-02-2026 | 11-05-2026 |
| Dividend Yield | ★ 2.62% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ 1.54 | N/A |
| Revenue | ★ $1,299,640,000.00 | $15,355,000.00 |
| Revenue This Year | $1.24 | N/A |
| Revenue Next Year | $2.48 | $57.21 |
| P/E Ratio | $58.03 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $74.15 | $5.26 |
| 52 Week High | $95.09 | $21.27 |
Technical Indicators
Market Signals| Indicator | OTTR | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 41.01 | 50.58 |
| Support Level | $84.46 | $18.03 |
| Resistance Level | $90.45 | $20.29 |
| Average True Range (ATR) | 1.66 | 0.84 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 10.49 | 62.88 |
Price Performance
Historical ComparisonAbout OTTR Otter Tail Corporation
Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.